• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.16% Nasdaq Down 0.13%

    Omeros Corporation (OMER)

    -NasdaqGM
    20.52 Down 0.03(0.15%) Jun 2, 4:00PM EDT
    |After Hours : 20.52 0.00 (0.00%) Jun 2, 4:32PM EDT
    Add to Portfolio
    Prev Close:20.55
    Open:20.27
    Bid:20.11 x 500
    Ask:21.25 x 100
    1y Target Est:44.20
    Beta:1.56
    Earnings Date:Aug 10 - Aug 14 (Est.)
    Day's Range:20.03 - 20.78
    52wk Range:11.18 - 27.64
    Volume:2,037,110
    Avg Vol (3m):541,519
    Market Cap:776.31M
    P/E (ttm):N/A
    EPS (ttm):-2.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    OMERDown 0.15%776.31M
    ACADUp 0.63%4.17B
    ALKSUp 1.16%9.07B
    HRTXDown 4.84%N/A

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):940.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-1.68
    Quarterly EPS Est (Jun-15) :-0.56
    Mean Recommendation*:1.8
    PEG Ratio (5 yr expected):-0.14

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Omeros Corporation, a biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback